Skip to content
Merito
← Back to results
EB-2 NIWHealthcare, clinicalIndividualDecided January 2026Dismissed

Outcome: Dismissed

JAN212026_07B5203

Merit and national importanceNot metWell positionedNot reached / not discussedBalance favors a waiverNot reached / not discussed

Our summary

Clinical trials specialist sought NIW for EB-2 to increase ethnic minority participation in drug development. AAO affirmed denial, finding the proposed seven-person business lacked sufficient national importance in healthcare or economy despite furthering a valid national goal of eliminating health disparities.

Official PDF

Official PDF ↗

Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.

No criterion in the table was found met in this decision.

What was missing

  • Merit and national importance · Proposed clinical trials business lacks demonstrated national health or economic implications at required scale

Criteria

CriterionReadingWhy
Merit and national importanceNot metProposed clinical trials business lacks demonstrated national health or economic implications at required scale
Well positionedNot reached / not discussedNot reached because first prong failed
Balance favors a waiverNot reached / not discussedNot reached because first prong failed

A published decision describes one case. It is not legal advice and not a prediction for yours.

Similar decisions

Decisions whose text is closest to this one.